Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT04330196
Other study ID # DEEP1C
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date July 8, 2020
Est. completion date December 3, 2020

Study information

Verified date February 2021
Source University Hospital Inselspital, Berne
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The primary objective of this study is to assess the effect of the natural course of postprandial hypoglycemia vs. a postprandial euglycaemic condition on driving performance in individuals with confirmed postprandial hyperinsulinaemic hypoglycaemia after gastric-bypass surgery.


Description:

Despite the increasing prevalence of postprandial hyperinsulinaemic hypoglycaemia (PHH), clinical implications are still unclear. Anecdotal evidence from patients with PHH suggest a high burden for these patients due to the recurrent hypoglycaemias with possibly debilitating consequences. It is well established, that even mild hypoglycaemia (plasma glucose of 3.4mmol/l) in diabetic and non-diabetic significantly impairs cognitive-motor functioning. Of note, some of the cognitive aspects remain impaired for up to 75min, even when the hypoglycaemia is corrected. In addition to the hypoglycaemic blood glucose levels per se, the dynamics of the hypoglycaemia occurrence appears to play a role. It was shown in individuals with type 1 diabetes, that cognitive functions are affected more during a fast-fall than slow fall hypoglycaemia in the postprandial state. Driving is a frequent daily activity which integrates various mental function including visual and auditory processing, motor skills, reasoning and problem solving. Due to the potentially dangerous consequences, avoidance of hypoglycaemia-induced driving mishaps is of uttermost importance. Several studies have evaluated the impact of induced, controlled hypoglycaemia in individuals with type 1 diabetes on driving performance using driving simulators but data in PHH patients are currently lacking. Assessing the potential impact of the natural course of postprandial hypoglycaemia on driving performance in PHH patients will contribute to a better understanding of the consequences and relevance of this problem. The investigator will test the hypothesis whether driving performance during the postprandial glucose dynamics is impaired in patients with confirmed PHH.


Recruitment information / eligibility

Status Completed
Enrollment 12
Est. completion date December 3, 2020
Est. primary completion date December 3, 2020
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: - Aged =18 years - Roux-en-Y gastric bypass =1 year ago - PHH defined as postprandial plasma or sensor glucose<3.0mmol/l according to the International Hypoglycaemia Study Group (1) and exclusion of other causes of hypoglycaemia - Possession of a valid Swiss driver's license. Passed driver's examination at least 3 years before study inclusion. Active driving in the last 6 months before the study. Exclusion Criteria: - Clinically relevant weight changes (=5%) within the past 3 months - Incapacity to give informant consent - Historical or current diabetes based on HbA1c =6.5% without glucose-lowering treatment - Haemoglobin level below 11 g/dl - Ongoing treatment with glucose-lowering drugs, anorectic drugs, steroids or any medications known to affect gastric motility - Active heart, lung, liver, gastrointestinal, renal or neurological disease - Inability to follow study procedures - Pregnancy or breast-feeding

Study Design


Intervention

Diagnostic Test:
Oral glucose tolerance test
Participant ingests 75g of glucose
Ingestion of placebo
Participant ingests 700mg of aspartame

Locations

Country Name City State
Switzerland Department of Diabetes, Endocrinology, Clinical Nutrition and Metabolism, Inselspital, Bern University Hospital Bern

Sponsors (1)

Lead Sponsor Collaborator
Lia Bally

Country where clinical trial is conducted

Switzerland, 

Outcome

Type Measure Description Time frame Safety issue
Other Time course of the hormonal response after glucose/aspartame intake Insulin, C-peptide, Adrenalin, Noradrenalin, Glucagon, Cortisol, Growth hormone, PYY will be measured in pre-defined timepoints From -15 to 120 minutes after glucose/aspartame intake
Other Heart rate after glucose/aspartame intake An ECG will be used to measure heart rate after glucose and aspartame intake From -15 to 180 minutes after glucose/aspartame intake
Primary Estimated difference in driving performance across driving features over the glycemic trajectory after glucose vs. aspartame intake The pooled effect (z-score difference), which is the compound change in driving performance across driving features between the glucose and aspartame condition, will be calculated using a Bayesian hierarchical regression model From -15 to 150 minutes after glucose/aspartame intake
Secondary Hypoglycemic symptoms over the glycemic trajectory after glucose vs. aspartame intake Hypoglycemic symptoms will be rated using the Edinburgh Hypoglycemia Symptom Scale (minimum score=11, maximum score=77, a higher score, means more symptoms) From -15 to 180 minutes after glucose/aspartame intake
Secondary Cognitive test performance after glucose vs. aspartame intake Cognitive function will be assessed using the Digit Symbol Substitution Test 135 minutes after glucose/aspartame intake
See also
  Status Clinical Trial Phase
Active, not recruiting NCT04422236 - A Post-market, Observational Registry With the easyEndoTM Universal Linear Cutting Stapler in Laparoscopic Bariatric Surgery
Withdrawn NCT04543526 - A Post-market Observational Study With the easyEndoTM Universal Linear Cutting Stapler in Standard Laparoscopic and Robot-assisted Laparoscopic Roux-en-Y Gastric Bypass (RYGB) Surgery
Completed NCT01867255 - Study to Examine the Effect of Gastric Bypass Surgery on Venlafaxine ER Blood Levels Phase 1
Completed NCT04334161 - Evaluation of the Neuro-endocrine Response to Post-prandial Hyperinsulinaemic Hypoglycaemia.
Completed NCT03440138 - Defining Benchmarks in Bariatric Surgery
Completed NCT04972357 - Bariatric Procedures and Changes Gastric Passage
Active, not recruiting NCT03049696 - Does Participation in a Pre-Operative Physical Activity Program Improve Patient Outcomes and Quality of Life? N/A
Not yet recruiting NCT06350955 - IV Iron-induced Hypophosphatemia After RYGB Phase 4
Completed NCT02128581 - A Dose-response of the Effects of Exendin-9,39 on GI Symptoms and Food Intake Phase 1
Completed NCT03478098 - Meal Glycaemic Index and Exercise After Gastric Bypass N/A
Recruiting NCT04808206 - A Registry of Laparoscopic Bariatric Surgery Using Stapling Devices: Observation of Safety and Clinical Efficacy
Completed NCT04600596 - Photographic Food Recognition and Meal Size Estimation Before and After Roux-en-Y Gastric Bypass
Completed NCT03968757 - Assessing the Safety and Performance of the easyEndoTM Universal Linear Cutting Stapler in Laparoscopic Gastric Bypass Surgery
Active, not recruiting NCT02068001 - Changes in Food Preference and Food Cue Responsivity After Bariatric Surgery N/A
Completed NCT02204813 - To Define the Role of GLP-1 for Improving Glucose Homeostasis in Humans Following Gastric Bypass Surgery Phase 1
Recruiting NCT04324515 - Randomized Trial Comparing Gastric Bypass With and Without Cholecystectomy N/A
Completed NCT05560789 - The Effect of Physical Activity in Individuals With Post-bariatric Hypoglycemia N/A
Not yet recruiting NCT04172116 - Continuous Glucose Monitoring (CGM) After Surgical Variations of the Roux-en-y Gastric Bypass
Completed NCT04609449 - A Comparison Between Short vs. Long Biliopancreatic Limb Gastric Bypass N/A
Completed NCT05216926 - Forecasting and Preventing Post-Bariatric Hypoglycaemia WP 3 N/A